Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Rufinamide Solution, 1.0 mg/mL in Acetonitrile:Water (9:1), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco R0231ML
Description
An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel™ in the US and Inovelon™ in the EU.
Specifications
75-05-8, 106308-44-5 | |
UN 1648 3 / PGII | |
238.19 | |
1 mL |
C10H8F2N4O | |
1.0 mg/mL in acetonitrile:water (9:1) | |
Ampule | |
2°C (35.6°F) - closed cup |
Safety and Handling
H332-H319
Recommended Storage : -20°C
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation
Spot an opportunity for improvement?Share a Content Correction